Skip to content

DRMAW

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−50.00%
Ask drillr

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.74
EPS estimate
-$0.55
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+12.1%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.55-$0.74Miss -34.55%—
May 13, 2026-$0.53-$0.48Beat 9.43%—
Mar 26, 2026-$1.54-$0.35Beat 77.27%—
Nov 14, 2025-$1.59-$1.65Miss -3.67%—
Aug 13, 2025-$2.90-$1.66Beat 42.86%—
May 14, 2025-$4.50-$0.45Beat 90.07%—
Sep 29, 2023—-$0.54——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026